BioCryst: 3Q Earnings Snapshot
DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a loss of $37.6 million in its third quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 34 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The drugmaker posted revenue of $1.8 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $4.5 million.
The company’s shares closed at $2.03. A year ago, they were trading at $7.93.